Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women

Climacteric

Volumn 17, Issue 6, 2014, Pages 692-699

  Liu, P J ^a   Ma, F ^a   Lou, H P ^a   Zhu, Y N ^a   Chen, Y ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

HEPATIC STEATOSIS; MENOPAUSE; NON ALCOHOLIC FATTY LIVER DISEASE; URIC ACID; WOMEN

Indexed keywords

CREATININE; GAMMA GLUTAMYLTRANSFERASE; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; POSTMENOPAUSE; SMOKING; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; BLOOD PRESSURE; BODY MASS; CHINA; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; ECHOGRAPHY; FATTY LIVER; HYPERLIPIDEMIAS; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE;

ADULT; AGED; BLOOD PRESSURE; BODY MASS INDEX; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; METABOLIC SYNDROME X; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; POSTMENOPAUSE; URIC ACID; WAIST CIRCUMFERENCE;

EID: 84911400912     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2014.926323     Document Type: Article

References (47)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-31
2. Fehér J., Németh E., Lengyel G. Non-Alcoholic steatohepatitis (NASH). Arch Med Sci 2005; 1: 37-47
3. Fan J G, S aibara T., Chitturi S., et al. What are the risk factors and settings for non-Alcoholic fatty liver disease in Asia-Pacifi c?. J Gastroenterol Hepatol 2007; 22: 794-800
4. Amarapurkar D N., Hashimoto E., Lesmana L A., et al. How common is non-Alcoholic fatty liver disease in the Asia-Pacifi c region and are there local differences?. J Gastroenterol Hepatol 2007; 22: 788-93
5. Caballeria L., Auladell M A., Toran P., et al. Prevalence and factors associated with the presence of non alcoholic fatty liver disease in an apparently healthy adult population in primary care units. BMC Gastroenterol 2007; 7: 41
6. Völzke H., Schwarz S., Baumeister SE., et al. Menopausal status and hepatic steatosis in a general female population. Gut 2007; 56: 594-5
7. Moon SS. Relationship between serum uric acid level and nonalcoholic fatty liver disease in pre- and postmenopausal women. Ann Nutr Metab 2013; 62: 158-63
8. Park SH., Jeon WK, Kim SH., et al. Prevalence and risk factors of non-Alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 2006; 21: 138-43
9. Suzuki A., Abdelmalek M F. Nonalcoholic fatty liver disease in women. Womens Health (Lond Engl) 2009; 5: 191-203
10. Lv Q., Meng X -F., He F -F, et al. High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-Analysis of prospective cohort studies. PLoS ONE 2013; 8: e56864
11. Mangge H., Zelzer S., Puerstner P, et al. Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults. Obesity (Silver Spring) 2013; 21: E71-7
12. Lippi G., Montagnana M., Luca Salvagno G., et al. Epidemiological association between uric acid concentration in plasma, lipoprotein(a), and the traditional lipid profi le. Clin Cardiol 2010; 33: E76-80
13. Yang T, Chu CH., Bai CH., et al. Uric acid concentration as a risk marker for blood pressure progression and incident hypertension: a Chinese cohort study. Metabolism 2012; 61: 1747-55
14. Culleton BF., Larson MG., Kannel WB., et al. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999; 131: 7-13
15. Lai S W., Tan C K., Ng K C. Epidemiology of hyperuricemia in the elderly. Yale J Biol Med 2001; 74: 151-7
16. Wingrove CS., Walton C., Stevenson JC. The effect of menopause on serum uric acid levels in non-obese healthy women. Metabolism 1998; 47: 435-8
17. Liu PJ, Ma F, Lou HP., et al. Relationship between serum uric acid levels and metabolic syndrome in Chinese postmenopausal women. Climacteric 2014; 17: 148-54
18. Xu C., Yu C., Xu L., et al. High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study. PLoS One 2010; 5: e11578
19. Li Y, Xu C., Yu C., et al. Association of serum uric acid level with non-Alcoholic fatty liver disease: a cross-sectional study. J Hepatol 2009; 50: 1029-34
20. Lee JW, Cho YK., Ryan M., et al. Serum uric acid as a predictor for the development of nonalcoholic fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver 2010; 4: 378-83
21. H wang IC., Suh SY., Suh AR., et al. The relationship between normal serum uric acid and nonalcoholic fatty liver disease. J Korean Med Sci 2011; 26: 386-91
22. Liu CJ. Prevalence and risk factors for non-Alcoholic fatty liver disease in Asian people who are not obese. J Gastroenterol Hepatol 2012; 27: 1555-60
23. Das K., Das K., Mukherjee P S., et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and signifi cant liver disease. Hepatology 2010; 51: 1593-602
24. Fan JG, Zhu J, Li XJ, e t al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 2005; 43: 508-14
25. Omagari K., Kadokawa Y., Masuda J., et al. Fatty liver in nonalcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol 2002; 17: 1098-105
26. Den Tonkelaar I., Broekmans F J, D e Boer E J., et al. The Stages of Reproductive Aging Workshop. Menopause 2002; 9: 463-5
27. Utian WH. The International Menopause Society menopauserelated terminology defi nitions. Climacteric 1999; 2: 284-6
28. Lohsoonthorn V, Dhanamun B., Williams MA. P revalence of hyperuricemia and its relationship with metabolic syndrome in Thai adults receiving annual health exams. Arch Med Res 2006; 37: 883-9
29. Grundy S M., Cleeman J I, D aniels S R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute Scientifi c Statement. Circulation 2005; 112: 2735-52
30. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1705-25
31. Joy D., Thava V R, S cott B B. Diagnosis of fatty liver disease: is biopsy necessary?. Eur J Gastroenterol Hepatol 2003; 15: 539-43
32. Farrell GC. NASH: what is it, and why is it important in the Asia-Pacifi c region?. J Gastroenterol Hepatol 2003; 18: 124-38
33. Chitturi S., Wong VW, Farrell G. Nonalcoholic fatty liver in Asia: fi rmly entrenched and rapidly gaining ground. J Gastroenterol Hepatol 2011; 26(Suppl 1): 163-72
34. Farrell GC., Chitturi S., Lau GKK., Sollano J., the Asia-Pacifi c Working Party on NAFLD. Guidelines for the assessment and management of non-Alcoholic fatty liver disease in the Asia-Pacifi c region. Executive summary. J Gastroenterol Hepatol 2007; 22: 775-7
35. Okanoue T, U memura A., Yasui K., et al. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan. J Gastroenterol Hepatol 2011; 26(Suppl 1): 153-62
36. Chitturi S., Abeygunasekera S., Farrell GC., et al. NASH and insulin resistance: insulin hypersecretion and specifi c association with the insulin resistance syndrome. Hepatology 2002; 35: 373-9
37. Wong V W, Hui AY., Tsang SW., et al. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-Alcoholic fatty liver disease. Aliment Pharmacol Ther 2006; 24: 1215-22
38. Choi HK, C urhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007; 116: 894-900
39. Bickel C., Rupprecht H J, B lankenberg S., et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002; 89: 12-17
40. Liu PW., Chang TY., Chen JD. Serum uric acid and metabolic syndrome in Taiwanese adults. Metabolism 2010; 59: 802-7
41. Godsland I F, L ecamwasam K., Johnston D G. A systematic evaluation of the insulin resistance syndrome as an independent risk factor for cardiovascular disease mortality and derivation of a clinical index. Metabolism 2011; 60: 1442-8
42. Feig DI., Kang DH., Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811-21
43. Lee HJ, Park HT., Cho GJ, et al. Relationship between uric acid and metabolic syndrome according to menopausal status. Gynecol Endocrinol 2011; 27: 406-11
44. Koga M., Saito H., Mukai M., et al. Factors contributing to increased serum urate in postmenopausal Japanese females. Climacteric 2009; 12: 146-52
45. Chen LK., Lin MH., Lai HY., et al. Uric acid: a surrogate of insulin resistance in older women. Maturitas 2008; 59: 55-61
46. Dawson J, Walters M. Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?. Br J Clin Pharmacol 2006; 62: 633-44
47. Clark J M, B rancati F L, D iehl A M. Nonalcoholic fatty liver disease. Gastroenterology 2002; 122: 1649-57